Dallas, TXCIK 20414365 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
1,015 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Invesco Exch Traded Fd Tr II | 954.8K | $16.17M | 10.1% | +899.2K | Added |
| 2 | Invesco Qqq Tr | 19.5K | $11.98M | 7.5% | +1.3K | Added |
| 3 | Eyepoint Pharmaceuticals Inc | 530.7K | $9.70M | 6.1% | 0 | Held |
| 4 | Vanguard Tax-Managed Fds |
| 154.0K |
| $9.62M |
| 6.0% |
| +53.4K |
| Added |
| 5 | Bny Mellon ETF Trust | 69.5K | $9.09M | 5.7% | +28.6K | Added |
| 6 | Spdr Series Trust | 79.5K | $6.56M | 4.1% | −12.5K | Reduced |
| 7 | Vanguard Intl Equity Index F | 110.8K | $5.96M | 3.7% | +14.9K | Added |
| 8 | Vanguard Scottsdale Fds | 63.9K | $5.35M | 3.3% | +27.1K | Added |
| 9 | Vanguard Intl Equity Index F | 72.2K | $5.31M | 3.3% | −8.9K | Reduced |
| 10 | Ishares Gold Tr | 54.7K | $4.44M | 2.8% | +6.5K | Added |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio